European Disease Progression Monitor
Delivers evidence on the effects of the disease
The EU5 are at a critical juncture
Many of the conclusions reached in Edition 6 remain
Many of the conclusions reached in Edition 6 remain (cont.)
Unprecedented investment and collaboration
A 12-month development timeline for a COVID-19 vaccine
Once a vaccine becomes available
The potential demand for a COVID-19 vaccine
There has been a growing number
Increased testing is giving a more
People over 75 account for
Emerging data across the EU5
A reduction in the number of people
The EU5 is at a critical juncture
All EU5 nations are nearing
The manner of easing the lockdown
Confirmed cases have continued
Disclaimer
Related Practice
Life Sciences & Pharma

Related Insights